A recent study conducted on CCA patients showed that high expression of ALDH1A1 correlated with a more favorable prognosis [48]; in many studies, ALDH1A1 is a cancer stem cell marker and a suitable target for therapy and only its activity is associated to worse prognosis [49, 50]. The gene discussed is ALDH1A1; the disease is cancer.